EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+29.65%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$55.8M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Top Buys
| 1 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
+$3.5M |
| 2 |
Weibo
WB
|
+$2.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.88M |
| 4 |
Deckers Outdoor
DECK
|
+$1.72M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1.55M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
+$20.3M |
| 2 |
Yum China
YUMC
|
+$12.8M |
| 3 |
Pinduoduo
PDD
|
+$10.6M |
| 4 |
TSMC
TSM
|
+$9.64M |
| 5 |
Apple
AAPL
|
+$4.98M |
Sector Composition
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Constellation Energy
CEG
$94B
| $373K | 0.02% |
3,189
-348
| -10% | -$40.7K |
|
202
Denali Therapeutics
DNLI
$2.25B
| $371K | 0.02% |
17,290
+5,509
| +47% | +$118K |
|
203
IDEAYA Biosciences
IDYA
$2.17B
| $369K | 0.02% |
+10,385
| New | +$369K |
|
204
Fastenal
FAST
$55B
| $369K | 0.02% |
11,380
-1,184
| -9% | -$38.3K |
|
205
TE Connectivity
TEL
$61.7B
| $368K | 0.02% |
2,622
-234
| -8% | -$32.9K |
|
206
Bank of America
BAC
$372B
| $367K | 0.02% |
10,912
+123
| +1% | +$4.14K |
|
207
Electronic Arts
EA
$41.5B
| $362K | 0.02% |
2,647
-294
| -10% | -$40.2K |
|
208
Pool Corp
POOL
$12B
| $362K | 0.02% |
+907
| New | +$362K |
|
|
SAGE
209
DELISTED
Sage Therapeutics
SAGE
| $357K | 0.02% |
16,482
-4,678
| -22% | -$101K |
|
210
Walmart
WMT
$816B
| $357K | 0.02% |
6,786
+105
| +2% | +$5.52K |
|
211
Exelon
EXC
$43.5B
| $356K | 0.02% |
9,913
-1,031
| -9% | -$37K |
|
212
CoStar Group
CSGP
$37.3B
| $355K | 0.02% |
4,067
-425
| -9% | -$37.1K |
|
213
Alibaba
BABA
$351B
| $348K | 0.02% |
4,488
-4,084
| -48% | -$317K |
|
214
Verisk Analytics
VRSK
$37.5B
| $345K | 0.02% |
1,444
-152
| -10% | -$36.3K |
|
215
Baker Hughes
BKR
$44.8B
| $342K | 0.02% |
10,019
-1,088
| -10% | -$37.2K |
|
216
Xcel Energy
XEL
$42.6B
| $340K | 0.02% |
5,494
-571
| -9% | -$35.4K |
|
217
McDonald's
MCD
$223B
| $339K | 0.02% |
1,143
+5
| +0.4% | +$1.48K |
|
218
AstraZeneca
AZN
$252B
| $338K | 0.02% |
5,012
-484
| -9% | -$32.6K |
|
219
Rocket Pharmaceuticals
RCKT
$346M
| $336K | 0.02% |
11,197
-1,215
| -10% | -$36.4K |
|
220
Arcellx
ACLX
$4B
| $334K | 0.02% |
6,012
-2,144
| -26% | -$119K |
|
|
CERE
221
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $322K | 0.02% |
7,599
-2,624
| -26% | -$111K |
|
222
Catalyst Pharmaceutical
CPRX
$2.45B
| $318K | 0.02% |
18,913
-7,307
| -28% | -$123K |
|
223
Atlassian
TEAM
$47.8B
| $317K | 0.02% |
1,334
-113
| -8% | -$26.9K |
|
224
DoorDash
DASH
$110B
| $316K | 0.02% |
+3,191
| New | +$316K |
|
225
Celldex Therapeutics
CLDX
$1.61B
| $315K | 0.02% |
7,949
-516
| -6% | -$20.5K |
|